Cargando…
Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
BACKGROUND AND AIM: The aim of this study is to evaluate whether the long-term (≥4 weeks) use of proton pump inhibitors (PPIs) is a risk factor for intubation requirement and mortality in patients hospitalized for COVID-19. MATERIALS AND METHODS: In this multicentric retrospective study, a total of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569806/ https://www.ncbi.nlm.nih.gov/pubmed/34110723 http://dx.doi.org/10.3906/sag-2103-80 |